Invuity’s patented Intelligent Photonics™ devices provide direct visualization of the surgical cavity enabling enhanced precision, efficiency and safety. Our technology is integrated into sophisticated retractor systems, handheld devices and intracavity drop-in illuminators; each utilizing our proprietary waveguide technology that directs and shapes light into broad, uniform illumination to provide enhanced direct visualization inside dark surgical cavities. In addition, it converts traditional thermally hot, concentrated light output to thermally cool volumetric illumination throughout the entire surgical cavity.
Transforming Minimal access Surgeries Through Advanced Visualization
Invuity is committed to leveraging advanced photonics technology to transform and create a new standard of care for minimal access surgery.
Increases borrowing capacity to up to $50 million Provides financial flexibility with interest-only payments on term loan for first 24 months New agreement will replace existing $15 million term loan and $7.5 million revolver with $30 million term loan and $20 million revolver SAN FRANCISCO, March 13, 2017 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that it signed a new debt agreement with MidCap Financial (“MidCap”) on March 10, 2017. The new facility consists of a $30 million term loan divided in two tranches. The first tranche of $20 million was funded upon closing and the additional $10 milli...Read More
Achieves revenue growth of 50% and gross margin expansion over prior year’s fourth quarter SAN FRANCISCO, Feb. 14, 2017 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today reported financial results for the three months and year ended December 31, 2016. Q4 2016 Highlights Revenue grew 50% to $9.4 million compared to revenue of $6.2 million in the 2015 fourth quarter. Gross margin expansion continued to 74.3% compared to 65.9% in the 2015 fourth quarter. Approximately 745 hospitals purchased Invuity devices in the fourth quarter of 2016, up from 530 hospitals in the fourth quarter of 2015. Approximat...Read More
SAN FRANCISCO, Feb. 06, 2017 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading surgical photonics company, today announced that company management is scheduled to present at the Leerink Partners 6th Annual Global Healthcare Conference on Thursday, February 16, 2017, at 3:00 p.m. ET in New York City. A live, listen-only webcast of the presentation may be accessed by visiting the Events & Presentations section of the Company's website at www.invuity.com under Investors & Media. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company's website for 30 days following the presentation. About Invuity® Invu...Read More
“Invuity’s Intelligent Photonics technology significantly improves the quality of illumination and enables me to better identify and visualize even in and around neural elements of the spine. I believe the technology has helped me be even more precise in my work.”
“I have noted a dramatic improvement in operative field visibility with Invuity’s Intelligent Photonics technology. This technology allows me and my assistant to see clearly without the need for a headlight, which makes me more efficient and improves safety.”
Scripps Health Care
La Jolla, CA
“The Invuity illuminated retractors are a must for anyone looking to do nipple sparing mastectomies. I feel we can save significant amounts of surgical time since we can see better without the worry of burn injury or fire hazard often found with fiber optic light.”
Past President, American Society of Breast Surgeons
Chief of Breast Surgery
Professor of Surgery, Weill Cornell Medical College
Edwin C. Weiskopf Professor of Surgical Oncology New York, NY